SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Holmstrom S) srt2:(2000-2004)"

Sökning: WFRF:(Holmstrom S) > (2000-2004)

  • Resultat 1-8 av 8
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Holmstrom, E., et al. (författare)
  • Fermi-surface effect on magnetic interlayer coupling
  • 2004
  • Ingår i: Physical Review B. Condensed Matter and Materials Physics. - 1098-0121 .- 1550-235X. ; 70:6
  • Tidskriftsartikel (refereegranskat)abstract
    • The oscillating magnetic interlayer coupling of Fe over spacer layers consisting of CuxPdt-x alloys is investigated by first principles density functional theory. The amplitude, period, and phase of the coupling, as well as the disorder-induced decay, are analyzed in detail and the consistency to the Ruderman-Kittel-Kasuya-Yoshida theory is discussed. An effect of the Fermi surface nesting strength on the amplitude is established from first principles calculations. An unexpected variation of the phase and disorder-induced decay is obtained and the results are discussed in terms of asymptotics.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  • Lopez, A, et al. (författare)
  • Durability of success after rectocele repair
  • 2001
  • Ingår i: International urogynecology journal and pelvic floor dysfunction. - 0937-3462. ; 12:2, s. 97-103
  • Tidskriftsartikel (refereegranskat)
  •  
7.
  •  
8.
  • Smeland, S, et al. (författare)
  • Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders
  • 2003
  • Ingår i: European Journal of Cancer. - 1879-0852. ; 39:4, s. 488-494
  • Tidskriftsartikel (refereegranskat)abstract
    • From 1990 to 1997, 113 eligible patients with classical osteosarcoma received neo-adjuvant chemotherapy consisting of high-dose methotrexate, cisplatin and doxorubicin. Good histological responders continued to receive the same therapy postoperatively, while poor responders received salvage therapy with an etoposide/ifosfamide combination. With a median follow-up of 83 months, the projected metastasis-free and overall survival rates at 5 years are 63 and 74%, respectively. Independent favourable prognostic factors for outcome were tumour volume < 190 ml, 24-h serum methotrexate > 4.5 muM and female gender. The etoposide/ifosfamide replacement combination did not improve outcome in the poor histological responders. In conclusion, this intensive multi-agent chemotherapy results in > 70% of patients with classical osteosarcoma surviving for 5 years. The data obtained from this non-randomised study do not support discontinuation and exchange of all drugs used preoperatively in histological poor responders. As observed in previous Scandinavian osteosarcoma studies, female gender appears to be a strong predictor of a favourable outcome. (C) 2003 Elsevier Science Ltd. All rights reserved.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-8 av 8

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy